Life sciences companies are facing increasing regulatory pressures from a technology perspective. Cybersecurity, cloud technology adoption and data integrity pose significant challenges for the management, security and control of data. The new General Data protection Regulation (“GDPR”) builds on the UK Data Protection Act 1998 and presents a significant shift in the approach to data protection and integrity. This webinar will examine this important new regulation and discuss its impact on life sciences (pharma, medical device, biotech, clinical, et al) companies and the technology and procedural framework to ensure success.